Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intractable eye pain: indication for triptans.

A May1, M A Gamulescu, U Bogdahn

  • 1Department of Neurology, University of Regensburg, Regensburg, Germany. arne.may@klinik.uni-regensburg.de

Cephalalgia : an International Journal of Headache
|June 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Father-separation and well-being in forcibly displaced Syrian children.

Attachment & human development·2024
Same author

Effect of hospitalization on equine local intestinal immunoglobulin A (IgA) concentration measured in feces.

Journal of equine veterinary science·2024
Same author

[DDB2-associated incidence of squamous cell carcinoma in Haflingers: risk minimization by genotyping].

Schweizer Archiv fur Tierheilkunde·2023
Same author

Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition.

Cancer medicine·2023
Same author

Magnetic charge propagation upon a 3D artificial spin-ice.

Nature communications·2021
Same author

Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort.

The Journal of infection·2021
Same journal

Cerebrovascular risk with calcitonin gene-related peptide monoclonal antibodies versus onabotulinumtoxinA in patients with migraine: A real-world pharmacoepidemiologic study in the National Institutes of Health All of Us Research Program.

Cephalalgia : an international journal of headache·2026
Same journal

Burning mouth syndrome and oral dysaesthetic/perceptual symptoms: Toward clinically actionable boundaries.

Cephalalgia : an international journal of headache·2026
Same journal

Effectiveness and clinical predictors of rimegepant for acute vertigo in vestibular migraine: A real-world cohort study.

Cephalalgia : an international journal of headache·2026
Same journal

Efficacy of digital therapeutic sinCephalea for personalised nutrition versus control for migraine prevention: A 12-week open-label randomised clinical trial.

Cephalalgia : an international journal of headache·2026
Same journal

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

Cephalalgia : an international journal of headache·2026
Same journal

Placebo or active comparator in chronic migraine trials: Balancing evidence and practicality.

Cephalalgia : an international journal of headache·2026
See all related articles

Sumatriptan, an anti-migraine drug, effectively managed pain after photorefractive keratectomy (PRK) eye surgery in 13 patients. Prophylactic dosing showed excellent efficacy for sustained pain control in these cases.

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Postoperative pain following eye surgery, such as photorefractive keratectomy (PRK), presents a significant challenge in patient management.
  • Intractable pain can severely impact patient comfort and recovery after ophthalmic procedures.

Purpose of the Study:

  • To evaluate the efficacy of sumatriptan, a selective 5-HT1B/1D agonist, in treating pain after photorefractive keratectomy (PRK).
  • To assess the potential of using an anti-migraine medication for managing ocular pain.

Main Methods:

  • A case series involving 13 patients (15 eyes) who underwent photorefractive keratectomy (PRK).
  • Sumatriptan was administered for the management of postoperative pain.
  • A subset of patients received a prophylactic second dose 4 hours after the initial dose.

Related Experiment Videos

Main Results:

  • All patients achieved a positive clinical response to sumatriptan for postoperative pain.
  • Excellent efficacy and stable pain control were observed in patients receiving a prophylactic second dose.
  • Sumatriptan demonstrated effectiveness in managing pain following PRK.

Conclusions:

  • Sumatriptan shows promise as a treatment option for pain management after photorefractive keratectomy (PRK).
  • Further controlled studies are warranted to confirm the utility of 5-HT1B/1D agonists in managing painful eye conditions.
  • The findings suggest a potential new therapeutic avenue for postoperative ophthalmic pain.